Bearish flow noted in Sarepta (SRPT) with 2,723 puts trading, or 1.9x expected. Most active are Jan-27 7.5 puts and Jan-27 50 calls, with total volume in those strikes near 2,400 contracts. The Put/Call Ratio is 1.75, while ATM IV is up over 2 points on the day. Earnings are expected on August 6th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Solid Biosciences initiated with a Buy at Citi
- Sarepta treatment of limb girdle muscular dystrophy granted orphan status
- Oppenheimer biotech analysts hold an analyst/industry conference call
- Sell Rating for Sarepta Therapeutics Amid FDA Investigation and Valuation Concerns
- FDA investigating risk of acute liver failure with Sarepta’s Elevidys